WeVote
Log In

Bill

Bill

PC 126

Para enmendar el inciso (c) del Artículo 5.12 de la Ley 247-2004, según enmendada, conocida como “Ley de Farmacia de Puerto Rico”, con el propósito de fomentar la investigación biológica, al atemperar la regulación estatal a las realidades de la ciencia moderna; y para otros fines relacionados.

2025-2028 Session

Puerto Rico bill modernizes pharmaceutical/biological research regulations under Pharmacy Law 247-2004 to align with current scientific standards and potentially boost biotech sector development.

Comisión no recomienda aprobación de la medida
0
WeVote Research Nonpartisan
Bill Summary · PC 126

Legislative bill overview

Bill PC 126 proposes amending Article 5.12(c) of Puerto Rico's Pharmacy Law (Law 247-2004) to modernize biological research regulations. The amendment aims to align state regulatory requirements with contemporary scientific practices and realities in biological research.

Why is this important

Biological research regulations directly affect pharmaceutical development, biotechnology innovation, and Puerto Rico's competitiveness in the life sciences sector. Modernizing outdated regulations could accelerate research timelines, attract biotech investment, and potentially improve drug development and medical treatments available to Puerto Rico residents.

Potential points of contention

  • Regulatory loosening concerns: Critics may worry that relaxing regulations to accommodate "modern science" could compromise safety standards, product quality control, or consumer protections if oversight mechanisms are reduced
  • Specificity of amendments: The bill's abstract language ("atemperar la regulación") lacks detail about which specific regulations are being modified, making it difficult to assess actual regulatory changes and their scope
  • Public health safeguards: Without seeing the specific amendments, there's uncertainty about whether patient safety protocols, contamination prevention, or quality assurance requirements remain adequately protected

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.